| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.082 | 0.2 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.2 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.078 | 0.2 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |